Gadolinium bopta multihance

Images were acquired on a 1.5T GE Signa scanner (General Electric Medical Systems, Milwaukee, WI), a 3T Philips Achieva scanner (Philips Healthcare, Best, The Netherlands), or a 3T Siemens Skyra scanner (Siemens AG, Munich, Germany). Image sequences and typical parameter ranges were: Diffusion tensor imaging (TR 4461-10500msec, TE 61.6-91.3 msec, 3.5mm slice thickness, 40 slices) used to generate trace diffusion weighted images (DWI) using three orthogonal directions (b = 0 and 1000 s/mm²) and apparent diffusion coefficient (ADC) maps; fluid attenuated inversion recovery (FLAIR) imaging (TR 9000 msec, TE 120-145 msec, 3.5 mm slice thickness, 40 slices); time-of-flight (TOF) MRA images (TR 18-23 msec, TE 3.43-6.8 msec, 0.75-1.4 mm slice thickness, 73-95 slices); gradient recall echo (GRE) images (TR 700-800 msec, TE 12-20.4 msec, 3.5-7 mm slice thickness, 20-40 slices); dynamic susceptibility contrast (DSC) perfusion weighted imaging (PWI) (TR 1-1.5 sec, TE 25-45 msec, 7mm slice thickness, 20 slices, 40-80 dynamics), which was collected during the injection of a weight-based dose of gadolinium (0.1mmol/kg of gadolinium-DPTA, Magnevist; Bayer Schering Pharma, Whippany, New Jersey or gadolinium-BOPTA Multihance, Bracco Diagnostics, Monroe Township, New Jersey).

Images were acquired on a 1.5T GE Signa scanner (General Electric Medical Systems, Milwaukee, WI), a 3T Siemens Skyra scanner (Siemens AG, Munich, Germany), or a 3T Philips Achieva scanner (Philips Healthcare, Best, The Netherlands). Image sequences and typical parameter ranges were: Diffusion tensor imaging (TR 4461-10500msec, TE 61.6-91.3 msec, 3.5mm slice thickness, 40 slices) used to generate trace diffusion weighted images (DWI) using three orthogonal directions (b = 0 and 1000 s/mm2) and apparent diffusion coefficient (ADC) maps; dynamic susceptibility contrast (DSC) PWI (TR 1-1.5 sec, TE 25-45 msec, 7mm slice thickness, 20 slices, 40-80 dynamics), which was collected during the injection of a weight-based dose of gadolinium (0.1mmol/kg of gadolinium-DPTA, Magnevist; Bayer Schering Pharma, Whippany, New Jersey or gadolinium-BOPTA Multihance, Bracco Diagnostics, Monroe Township, New Jersey); FLAIR imaging (TR 9000 msec, TE 120-145 msec, 3.5 mm slice thickness, 40 slices); time-of-flight magnetic resonance angiography (MRA) images (TR 18-23 msec, TE 3.43-6.8 msec, 0.75-1.4 mm slice thickness, 73-95 slices); gradient recall echo (GRE) images (TR 700-800 msec, TE 12-20.4 msec, 3.5-7mm slice thickness, 20-40 slices).

Images were acquired on a 1.5T GE Signa scanner (General Electric Medical Systems, Milwaukee, WI), a 3T Philips Achieva scanner (Philips Healthcare, Best, The Netherlands), or a 3T Siemens Skyra scanner (Siemens AG, Munich, Germany). Image sequences and typical parameter ranges were: Diffusion tensor imaging (TR 4461–10500msec, TE 61.6–91.3 msec, 3.5mm slice thickness, 40 slices) used to generate trace diffusion weighted images (DWI) using three orthogonal directions (b = 0 and 1000 s/mm²) and apparent diffusion coefficient maps; FLAIR imaging (TR 9000 msec, TE 120–145 msec, 3.5 mm slice thickness, 40 slices); time-of-flight magnetic resonance angiography images (TR 18–23 msec, TE 3.43–6.8 msec, 0.75–1.4 mm slice thickness, 73–95 slices); gradient recall echo (GRE) images (TR 700–800 msec, TE 12–20.4 msec, 3.5–7 mm slice thickness, 20–40 slices); dynamic susceptibility contrast PWI (TR 1–1.5 sec, TE 25–45 msec, 7mm slice thickness, 20 slices with full brain coverage, 40–80 dynamics), which was collected during the injection of a weight-based dose of gadolinium (0.1mmol/kg of gadolinium-DPTA, Magnevist; Bayer Schering Pharma, Whippany, New Jersey or gadolinium-BOPTA Multihance, Bracco Diagnostics, Monroe Township, New Jersey) at a flow rate of 5 mL/sec.